Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;331 (10 December), doi:10.1136/bmj.331.7529.0-b
Evidence on the effects of paying doctors for recruiting participants to trials is scarce and inconclusive. In a systematic review (p 1377), Bryant and Powell found only a few studies of inadequate quality. Given the important associated issues such as potential conflict of interest, implications for informed consent and the doctor-patient relationship, and resource implications, the authors argue that robust evidence from well conducted trials is needed before publicly funded research programmes can consider adopting many pharmaceutical companies' practice of paying doctors for recruitment.
|
|
Credit: VANESSA KELLAS/REX
|
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
What can you learn from this BMJ paper? Read Leanne Tite's Paper+